Baker R - Search Results

1

Potential supplementary utility of combined PFA-100 and functional von Willebrand factor testing for the laboratory assessment of desmopressin and factor concentrate therapy in von Willebrand disease.

Favaloro EJ, Thom J, Patterson D, Just S, Baccala M, Dixon T, Meiring M, Koutts J, Rowell J, Baker R. Favaloro EJ, et al. Among authors: baker r. Blood Coagul Fibrinolysis. 2009 Sep;20(6):475-83. doi: 10.1097/MBC.0b013e32832da1ad. Blood Coagul Fibrinolysis. 2009. PMID: 19584715

2

Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?

Favaloro EJ, Thom J, Patterson D, Just S, Dixon T, Koutts J, Baccala M, Rowell J, Baker R. Favaloro EJ, et al. Among authors: baker r. Thromb Res. 2009 Apr;123(6):862-8. doi: 10.1016/j.thromres.2008.10.008. Epub 2008 Dec 7. Thromb Res. 2009. PMID: 19064279

3

Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.

Favaloro EJ, Lloyd J, Rowell J, Baker R, Rickard K, Kershaw G, Street A, Scarff K, Barrese G, Maher D, McLachlan AJ. Favaloro EJ, et al. Among authors: baker r. Thromb Haemost. 2007 Jun;97(6):922-30. Thromb Haemost. 2007. PMID: 17549293 Clinical Trial.

4

Assessment of current diagnostic practice and efficacy in testing for von Willebrand's disorder: results from the second Australasian multi-laboratory survey.

Favaloro EJ, Thom J, Baker R; Australasian Society for Thrombosis and Haemostasis (ASTH) Emerging Technologies Group. Favaloro EJ, et al. Among authors: baker r. Blood Coagul Fibrinolysis. 2000 Dec;11(8):729-37. doi: 10.1097/00001721-200012000-00006. Blood Coagul Fibrinolysis. 2000. PMID: 11132651

5

Neutralising rivaroxaban induced interference in laboratory testing for lupus anticoagulant (LA): A comparative study using DOAC Stop and andexanet alfa.

Favaloro EJ, Gilmore G, Arunachalam S, Mohammed S, Baker R. Favaloro EJ, et al. Among authors: baker r. Thromb Res. 2019 Aug;180:10-19. doi: 10.1016/j.thromres.2019.05.013. Epub 2019 May 24. Thromb Res. 2019. PMID: 31158643

6

Reducing the effect of DOAC interference in laboratory testing for factor VIII and factor IX: A comparative study using DOAC Stop and andexanet alfa to neutralize rivaroxaban effects.

Favaloro EJ, Gilmore G, Bonar R, Dean E, Arunachalam S, Mohammed S, Baker R. Favaloro EJ, et al. Among authors: baker r. Haemophilia. 2020 Mar;26(2):354-362. doi: 10.1111/hae.13930. Epub 2020 Jan 21. Haemophilia. 2020. PMID: 31962376

7

Laboratory diagnosis of von Willebrand disorder: use of multiple functional assays reduces diagnostic error rates.

Favaloro EJ, Bonar R, Kershaw G, Sioufi J, Thom J, Baker R, Hertzberg M, Street A, Lloyd J, Marsden K; Royal College Of Pathologists Of Australasia Quality Assurance Program In Haematology. Favaloro EJ, et al. Among authors: baker r. Lab Hematol. 2005;11(2):91-7. doi: 10.1532/LH96.04063. Lab Hematol. 2005. PMID: 16024332

8

Reducing errors in identification of von Willebrand disease: the experience of the royal college of pathologists of australasia quality assurance program.

Favaloro EJ, Bonar R, Kershaw G, Sioufi J, Baker R, Hertzberg M, Street A, Marsden K. Favaloro EJ, et al. Among authors: baker r. Semin Thromb Hemost. 2006 Jul;32(5):505-13. doi: 10.1055/s-2006-947865. Semin Thromb Hemost. 2006. PMID: 16862524

9

Type 2B von Willebrand's disease in thirteen individuals from five unrelated Australian families: phenotype and genotype correlations.

Facey DA, Favaloro EJ, Maxwell E, Baker R, Hertzberg MS. Facey DA, et al. Among authors: baker r. Am J Hematol. 2000 Apr;63(4):197-9. doi: 10.1002/(sici)1096-8652(200004)63:4<197::aid-ajh6>3.0.co;2-2. Am J Hematol. 2000. PMID: 10706763 Free article.

10

Determination of activated protein C resistance in anticoagulated and lupus positive patients.

Ivey LM, Thom JY, Ivey JG, Baker RI. Ivey LM, et al. Among authors: baker ri. Blood Coagul Fibrinolysis. 2000 Jul;11(5):439-45. doi: 10.1097/00001721-200007000-00007. Blood Coagul Fibrinolysis. 2000. PMID: 10937805

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,351 results

Search Page

Filters